Lousdal Mette L, Kristiansen Ivar S, Møller Bjørn, Støvring Henrik
Department of Public Health, Aarhus University, Bartholins Allé 2, Aarhus C DK-8000, Denmark.
Department of Health Management and Health Economics, Oslo University, PO Box 1089, Oslo N-0317, Norway.
Br J Cancer. 2016 Mar 1;114(5):590-6. doi: 10.1038/bjc.2016.8. Epub 2016 Feb 2.
We aimed to estimate the effect of organised mammography screening on breast cancer stage distribution by comparing changes in women eligible for screening, based on birth cohort, to the concurrent changes in younger, ineligible women.
In an open cohort study in Norway, which introduced national mammography screening county-by-county from 1995 to 2004, we identified women (n=49 883) diagnosed with in situ or invasive breast cancer (ICD10 codes: D05 or C50) during the period 1987-2011 and born between 1917 and 1980. We estimated relative incidence rate ratios (rIRRs) comparing the development in the screening vs historic group to the younger vs younger historic group.
Including the compensatory drop, eligible women experienced a 68% higher increase in localised cancers (rIRR=1.68, 95% confidence interval (CI): 1.51-1.87) than younger women, while the increase in incidence of advanced cancers was similar (rIRR=1.11, 95% CI: 0.90-1.36). Excluding the prevalence round, eligible women experienced a 60% higher increase in localised cancers (rIRR=1.60, 95% CI: 1.42-1.79), while the increase in incidence of advanced cancers remained similar (rIRR=1.08, 95% CI: 0.86-1.35).
Introduction of organised mammography screening was followed by a significant increase in localised and no change in advanced-stage cancers in women eligible for screening relative to younger, ineligible women.
我们旨在通过比较基于出生队列符合筛查条件的女性的变化与同期不符合条件的年轻女性的变化,来评估有组织的乳腺钼靶筛查对乳腺癌分期分布的影响。
在挪威的一项开放队列研究中,该国于1995年至2004年逐县引入了全国性乳腺钼靶筛查,我们确定了在1987 - 2011年期间被诊断为原位或浸润性乳腺癌(ICD10编码:D05或C50)且出生于1917年至1980年之间的女性(n = 49883)。我们估计了相对发病率比(rIRRs),以比较筛查组与历史组的发展情况以及年轻组与年轻历史组的发展情况。
包括补偿性下降在内,符合条件的女性局部癌症的增加幅度比年轻女性高68%(rIRR = 1.68,95%置信区间(CI):1.51 - 1.87),而晚期癌症发病率的增加幅度相似(rIRR = 1.11,95% CI:0.90 - 1.36)。排除患病率阶段后,符合条件的女性局部癌症的增加幅度高60%(rIRR = 1.60,95% CI:1.42 - 1.79),而晚期癌症发病率的增加幅度仍然相似(rIRR = 1.08,95% CI:0.86 - 1.35)。
相对于不符合条件的年轻女性,引入有组织的乳腺钼靶筛查后,符合筛查条件的女性局部癌症显著增加,晚期癌症无变化。